A new phenylethanoid glycoside acylated with syringic acid, namely acanmontanoside, was isolated from the aerial portions of Acanthus montanus (Nees).
Introduction
As part of our systematic investigation on plants in the genus Acanthus of the family Acanthaceae, we reported the constituents of Acanthus ilicifolius L., [1] [2] [3] A. ebracteatus Vahl, [4] A. volubilis Wall [5] . To further study plants in the same genus, we investigated the chemical constituents of A. montanus (Nees) T. Anderson, cultivated at the Botanical Garden of the Faculty of Pharmaceutical
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Sciences, Khon Kaen University, Thailand. There is no mention on the medicinal uses of this plant in Thai traditional medicine since it is an exotic plant, but its leaves or whole plants are used in African countries for treatment of several ailments such as cough, gastritis, epilepsy, urinary disorders and rheumatic pains. The antimicrobial, anti-inflammatory, analgesic, antipyretic and smooth muscle relaxant properties of the leaf extracts have been reported [6] [7] [8] [9] . Previous phytochemical studies of this plant reported the presence of pentacyclic triterpenoids [10, 11] . The present paper describes the isolation and structural determination of polar chemical constituents from the aerial portions of this plant, including a new phenylethanoid glycoside 1 bearing a syringyl moiety, in addition to four phenylethanoid glycosides 2−5, two benzoxazinoid glucosides 6, 7, and two aliphatic alcohol glycosides 8, 9.
Results and Discussion
The methanolic extract of the aerial portions of A. montanus was suspended in H 2 O and partitioned with Et 2 O. The aqueous layer was applied to a Diaion HP-20 column, and eluted successively with H 2 O, MeOH and Me 2 CO. The fraction eluted with MeOH was separated by a combination of chromatographic techniques to afford a new phenylethanoid glycoside 1 ( Figure 1 ) together with eight known compounds, identified as decaffeoylverbascoside (2) (8) and ebractatoside B (9) by comparison of physical data with literature values and spectroscopic evidence [2, 4, 12] . (3) revealed the downfield shift of C-4"' (+2.5 ppm) together with the upfield shifts of C-3"' (−1.3 ppm) and C-5"' (−2.4 ppm) of the rhanmopyranosyl unit indicating that the syringyl group is an ester located at C-4"' of the rhamnopyranosyl moiety [4] . The assignments were supported by the results from COSY, HMQC and HMBC experiments. In the HMBC spectrum, the significant correlation was found between H-4"' and C-7"" as illustrated in Figure 2 . Therefore, the structure of this compound was elucidated as 4"'-O-syringyl-verbascoside, namely acanmontanoside. 
Extraction and Isolation
Dried aerial portions of A. montanus (1.0 kg) were extracted with MeOH three times (5.0 L each) at room temperature. After removal of the solvent by evaporation, the greenish residue (105.1 g) was suspended in H 2 O and partitioned with Et 2 O three times (1.0 L each). The aqueous layer was applied to a column of Diaion HP-20 and eluted successively with H 2 O, MeOH, and Me 2 CO. The fraction eluted with MeOH (10.5 g) was concentrated to dryness and subjected to a silica gel column using solvent systems I (3.0 lit), II (5.0 lit), III (3.0 lit), and IV (1.0 lit). Six fractions were collected (A to F). Fraction A (2.1 g) was applied to a column of RP-18 using solvent system V to provide six fractions. Fractions A-4 was purified by preparative HPLC-ODS with solvent system VIII to yield verbascoside (3, 34.3 mg), isoverbascoside (4, 36.6 mg). Fraction A-4 was purified by preparative HPLC-ODS with solvent system VIII to give leucosceptoside A (5, 32.3 mg), and the new phenylethanoid compound, acanmontanoside (1, 34.5 mg). Fraction B (1.4 g) was subjected to a column of RP-18 using solvent system V to afford five fractions. Fraction B-2 was purified by preparative HPLC-ODS with solvent system VII to provide (2R)-2-O-β-D-glucopyranosyl-2H-1,4-benzoxazin-3(4H)-one (6, 15.6 mg). Fraction C (1.4 g) was separated on a column of RP-18 using solvent system V to give nine fractions. Fraction C-1 was further purified by preparative HPLC-ODS with solvent system VI to provide decaffeoylverbascoside (2, 55.5 mg). Fraction C-2 was purified by preparative HPLC-ODS with solvent system VII to obtain (2R)-2-O-β-D-glucopyranosyl-4-hydroxy-2H-1,4-benzoxazin-3(4H)-one (7, 172.0 mg). Fraction C-7 was further purified by preparative HPLC-ODS with solvent system IX to afford (3R)-1-octen-3-ol-3-O-β-D-xylopyranosyl-(1→6)-O-β-D-glucopyranoside (8, 37.0 mg). Fraction D (2.2 g) was similarly separated on a column of RP-18 using solvent system V to afford eight fractions. Fraction D-6 was purified by preparative HPLC-ODS with solvent system IX to provide ebracteatoside B (9, 32.2 mg). 
Acanmontanoside

Conclusions
The present study isolated phenylethanoid glycosides 1-5, benzoxazinoid glucosides 6, 7, and aliphatic alcohol glycosides 8, 9 from the aerial parts of A. montanus. These types of compounds have previously been reported in Acanthus species [1] [2] [3] [4] [5] . It provides further confirmation of the typical profile of secondary metabolites found in this genus.
